Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.

Saved in:
Bibliographic Details
Title: Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.
Authors: Topham JT; Pancreas Centre BC, Vancouver, British Columbia, Canada., Karasinska JM; Pancreas Centre BC, Vancouver, British Columbia, Canada., Lee MKC; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Csizmok V; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Williamson LM; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Jang GH; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Denroche RE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Tsang ES; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Kalloger SE; Pancreas Centre BC, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Wong HL; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., O'Kane GM; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Moore RA; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Notta F; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Loree JM; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Wilson JM; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Bathe O; The University of Calgary, Calgary, Alberta, Canada., Tang PA; The University of Calgary, Calgary, Alberta, Canada., Goodwin R; The Ottawa Hospital Cancer Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Knox JJ; University Health Network, University of Toronto, Toronto, Ontario, Canada., Gallinger S; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada., Laskin J; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Jones SJM; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Renouf DJ; Pancreas Centre BC, Vancouver, British Columbia, Canada.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Schaeffer DF; Pancreas Centre BC, Vancouver, British Columbia, Canada. David.Schaeffer@vch.ca.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 150-157. Date of Electronic Publication: 2020 Oct 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first